Loading news...
Examine Ametek's (AME) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
BERWYN, Pa., Feb. 12, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its Board of Directors has approved a 10% increase in its quarterly cash dividend on common stock to $0.34 per share from $0.31 per share.
The Zacks Electronics -Testing Equipment industry players, such as AME, FTV and CGNX, are poised to benefit from the solid demand for testing instruments.
AME beats Q4 estimates as earnings rise 7.5% Y/Y and revenues jump 13.4%, driven by solid growth across both operating segments.
Revenue: Fourth-quarter sales were a record $2 billion, up 13% from the same period in 2024.Organic Sales Growth: Up 5% in the fourth quarter.Operating Income:
AMETEK, Inc. (AME) Q4 2025 Earnings Call Transcript
The headline numbers for Ametek (AME) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ametek (AME) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.94 per share. This compares to earnings of $1.87 per share a year ago.
TORONTO and PARK CITY, Utah, Feb. 3, 2026 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces the sale of LKC Technologies to AMETEK, Inc. (NYSE: AME). As leaders in the world of visual electrophysiology, LKC Technologies, a portfolio company of DW Healthcare Partners' Founders Fund, is dedicated to preserving sight by expanding access to objective functional retinal assessments.
BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced the acquisition of LKC Technologies, a leading provider of innovative technologies to enable the effective diagnosis and management of ophthalmic conditions.
BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the fourth quarter ended December 31, 2025.
Besides Wall Street's top-and-bottom-line estimates for Ametek (AME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Ametek (AME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like NVDA, AME, ATI and CRS offer strong growth potential.
Does Ametek (AME) have what it takes to be a top stock pick for momentum investors? Let's find out.
AMETEK is up 17% YoY as growth reaccelerates: Q3 revenue +10.8% YoY and operating income +11.4%, supported by rising margins and strong cash flow. The “AMETEK Growth Model” is back in focus: operational excellence, new products, global expansion, and bolt-on M&A are lifting orders, earnings, and guidance. Region/market trends improved: Europe surprised with double-digit growth; A&D led with low double-digit organic growth, while Power/Industrial and Process stayed solid; China lagged.
- Earnings to be released before market opens on Tuesday, February 3, 2026 - BERWYN, Pa., Jan. 15, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) will issue its fourth quarter 2025 earnings release before the market opens on Tuesday, February 3, 2026.
Ametek (AME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Does Ametek (AME) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Investment Committee debate the latest Calls of the Day.